Showing results (61-70 of 147) with videos related to

Sort By:
Pageof 15
Cancer Medicine|November 17, 2022
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patientsYue Hao, Gen Lin, Jing Xiang, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 24, 2024
The influence of PD-L1 expression levels on the efficacy of combination therapy in thymic epithelial tumorsHan Si, Xiaoshuang Fu, Yue Hao, et al.
Translational Oncology|September 20, 2023
Clinical characteristics and treatment efficacy of immune checkpoint inhibitors (ICIs) in patients with ICIs-induced Adrenal insufficiencyJing Xiang, Xueni Liu, Yue Hao, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|November 16, 2018
Comparison of Rearranged During Transfection (RET) Gene Rearrangements in Primary Versus Metastatic Non-Small Cell Lung Cancer (NSCLC)Quxia Zhang, Chunwei Xu, Wenxian Wang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|May 2, 2018
Xihuang pill promotes apoptosis of Treg cells in the tumor microenvironment in 4T1 mouse breast cancer by upregulating MEKK1/SEK1/JNK1/AP-1 pathwayLiang Su, Yiming Jiang, Yu Xu, et al.
Frontiers in Microbiology|May 27, 2022
Detoxification of Aflatoxin B1 by a Potential Probiotic Bacillus amyloliquefaciens WF2020Guojun Chen, Qian'an Fang, Zhenlin Liao, et al.
Lung Cancer (Amsterdam, Netherlands)|March 14, 2021
Genomic alterations and clinical outcomes in patients with lung adenocarcinoma with transformation to small cell lung cancer after treatment with EGFR tyrosine kinase inhibitors: A multicenter retrospective studyWenxian Wang, Chunwei Xu, Huafei Chen, et al.
BMC Medicine|May 9, 2022
Apatinib in patients with recurrent or metastatic thymic epithelial tumor: a single-arm, multicenter, open-label, phase II trialZhengbo Song, Guangyuan Lou, Yina Wang, et al.
Frontiers in Molecular Biosciences|July 11, 2022
DNA Damage Response Gene-Based Subtypes Associated With Clinical Outcomes in Early-Stage Lung AdenocarcinomaYang Zhao, Bei Qing, Chunwei Xu, et al.
Open Medicine (Warsaw, Poland)|March 14, 2023
Efficacy of immune checkpoint inhibitors in patients with KRAS-mutant advanced non-small cell lung cancer: A retrospective analysisXiaodong Gu, Jinfei Si, Yelan Guan, et al.
Pageof 15